Dear Sir, I am Balajee Ghosh, a patient of Type-2 Diabetes since 1997 ( at the age of 28 yrs) and I am under Insulin doses since 2007 along with oral medicines also. Presently I am taking medicines like Zeta plus, Jemer 2 DS with Insulin ( 30-30) and Thyronorm 75, Ramcor-5 (0-1), Rozucar 20 (0-1), Deplatt-75 (0-1). My present test reports are as followes : Creatinine 1, Albumin Creatinine Ratio-73, TSH-1.48, HBA1C-7.5, Fasting sugar 136 ( reports as on 14-02-16) and on being consulted with Nephrologist, I have been prescribed with Renolog (2-2-2) for three months on 02-03-16. Is it ok with me? PL ADVISE.
                                                        
                                                     
                                                    
                                                        
                                                            
                                                            
                                                            
                                                                posted on
                                                            
                                                                Sat, 12 Mar 2016 
                                                            
                                                            
                                                            
                                                            
                                                                
                                                                    
                                                                    
                                                                    Mon, 21 Mar 2016
                                                                    
                                                                    
  Answered on 
                                                                 
                                                                
                                                                    
                                                                    
                                                                    Tue, 22 Mar 2016
                                                                    
                                                                    
  Last reviewed on